Connect with us

Cannabis News

Military To Start Testing Service Members For The Psychedelic Psilocin, Memo Shows

Published

on

The US Department of Defense (DOD) is spreading a list of medicines, psychedelic compounds of military services, which will test one of the two main components of psilocybin mushrooms.

In a note obtained by Marihuana Moment, the Dod’s Defense Clerks worked on staff and readiness, Psilocin will be added to the drug testing of drug testing for the drug demand for drug reduction program.

Notes, on 18 August, the risk of politics “is the risk of disabilities and subsequent security, readiness, readiness, good application and disciplinary

“Service members are the issue of security and readiness, and the Department must adapt to our detection and determination program to deal with new drug threats and those who are creating”, Dr. Merlynn Carson.

The DED official said the memory attachment is “concentrations” to establish a positive test of PSilocin and other positive drug panel drugs.

Marijuana moment came to Dod for copies of attachments, but representatives could not immediately provide documents.

“The Department of Defense maintains a zero tolerance policy that prohibits drug consumption and we are committed to expanding our educational and preventive efforts, providing effective information about the misuse of drugs, including the use of psilocine”

Notes, “priority” will be given to Psilocin’s tests in the “Proofed Drug Panel”, the causes, permission or authority received in the protection of the authority. “

“In proportion to laboratory skills and capacity, the second priority will be given to special test requests for other collections, such as conventional inspection collections and grains can also be tested for PSilocin,” he says.

Dod has taken it to Psilocin to Test at the same time, carrying A Psychedelic Therapy of Congress Psychedelic Pilot Program for members and veterans of duty services. The most recent dod covered expenses should “progress report” in this initiative.

This latest note also comes two months since the Dod contractor federal government sued, reporting that Questions about the use of the latest marijuana in the security document The fifth amendment violated against self-discrimination.

While the final update of the Dod Policy had a psychedelic compound, they have also made a balloon for federal staff in recent years in recent years, as more individual states legalized drugs.

In February, the employees of the Air Force Massachusetts warned not only massachuan, but also cannabinoids derived from hemp, including CBD and Delta-8 thc, are prohibited in military base and related properties.

The department of defense and military branch warns that service members and other military workers are prohibited using cannabis products. In 2022, for example, air force It has not been taken into account the use of the CBD infusion of Sanitizer or Kalamu Granola can undesirable “military readiness”.

A first attempt at the US military to communicate his banabis ban It was the form of a fake press conference In 2019, officials asked script questions that are against cannabis against leaf cannabis to clean cats with CBD shampoos. Dod was staged about the time that his coding Intoxicating rules around Cannabinoid.

After the initial announcement of the 2019, the Department confirmed that CBD has limits on service members In notes published in 2020.

The hemp was legalized for about a year later, the air force sent a note Also warn against using CBD products typically found in the market. Air Force’s Massachusetts told pilots in 2021 to deal with disciplinary action Has hemp kind of having any kind of productEven if “your pet”.

Officials with a military office also said that his previous year wants his members carefully around “Grandma’s sticky miracles” This can have marijuana.

The Army, for his part, gave the initial release in 2018 to inform Are in favor of using CBD and Kalamu products No matter their legality. He then released an update in 2020 Explaining why the change of the rule gave.

The coastal guardian said Marinel cannot use marijuana Or visit the legal dyspension.

The factor that can affect these policy updates is the administration of substance abuse and mental health services 2019 Federal Agency Drug Program Coordinators Liberation of Orientation He explained concerns about the inflection of CBD products and the drug test has failed. Agency A update warning has been provided In 2020 more states voted for the legalization of marijuana.

One by one, in 2022 he said in general The strength of the air and space was reviewing marijuana policies And considering that a potential procurement may have a “common sense” if they are positive to cannabis.

In the meantime, the last time The role of a couple of policy in a couple of truck industry, for example, said the sector was about 80,000 drivers in the last year-Inused grain, positive marijuana were the marijuana transport department (dot) zero tolerance drug policy zero, zero tolerance.

US Supreme Court in April A Cannabis company sued for a truck after shooting for a positive THC test He said consuming the CBD product derived from hemp.

Separately, substance abuse and mental health services administration (samhsa) official this year before Criticism of a drug testing drug testing “means a drug test” means Canavies use cannabis to do with the nearby impunityA couple of days while avoiding drug test. “

Read Dod notice Psilocin drug tests below:

Photo courtesy Wikimedia / Employee.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

(Tagstotranslate) highlighted

Continue Reading

Cannabis News

Klasmann-Deilmann announces management changes

Published

on

By











After fifteen years of successful cooperation, managing director Moritz Böcking and the shareholders of Klasmann-Deilmann GmbH have mutually agreed to part ways. As of May 1, 2026, Moritz Böcking will hand over the position of managing director to Jan Astrup, who served as the company’s CEO in 2021/2022. Jan Astrup and Damian Ikemann will form the Board of Directors of the Klasmann-Deilmann Group from now on.

© Klasmann-Deilmann Benelux

Klasmann-Deilmann thanks Moritz Böcking for his cooperation and the progress achieved in the transformation of the Klasmann-Deilmann Group. Moritz Böcking expanded Klasmann-Deilmann beyond the growing media business into new areas of commercial horticulture and promoted innovation and digitalization within the company. In addition, its achievements include the expansion of resources derived from renewable raw materials, as well as the acquisition of a subsidiary in Australia and production facilities in France and Canada, which operate in cooperation with external partners. He also significantly advanced Klasmann-Deilmann’s positioning as a global pioneer of sustainable development in the growing media industry, thereby making a decisive contribution to the company’s economic growth.

With Jan Astrup, Klasmann-Deilmann is getting an internationally experienced manager who has proven himself in the company and has extensive experience in raw materials, production, process optimization and technology. With the new CEO, raw materials and technology-driven areas for the substrate industry are now increasingly important at senior management level. Jan Astrup will strengthen the core commercial horticulture business and help develop the company for the future.

For more information:
Klasmann-Deilmann GmbH
(email protected)
www.klasmann-deilmann.com



Publication date:













Continue Reading

Cannabis News

Congressional Amendments To Delay Or Speed Up Federal Hemp THC Product Ban Won’t Get Votes

Published

on

By

Congressional amendments to both delaying the scheduled federal recriminalization of hemp THC products for another year or to speed up implementation will not be considered on the House floor this week.

Rep. James Comer (R-KY) introduced the delay proposal as an amendment to the Farm Bill, while Rep. Mary Miller (R-IL) introduced an expedited approach. Neither will move forward, however, with Comer withdrawing his measure and the House Rules Committee failing to vote on Miller’s.

Hemp derivatives containing less than 0.3 percent delta-9 THC by weight of the drug were made federally legal under the 2018 Farm Bill signed by President Donald Trump in his first term. But late last year, Trump signed new legislation containing provisions that will redefine hemp so that only products with a total of 0.4 milligrams of THC per container will be legal starting Nov. 12.

Comer’s amendment, sponsored by Reps. Kelly Morrison (D-MN), Ilhan Omar (D-MN) and Morgan Griffith (R-VA), would have delayed the ban until November 2027.

According to Miller’s proposal, however, the ban will begin the day the new Farm Bill takes effect. However, it is unclear based on progress in Congress whether the large-scale farming legislation will actually become law, and the legislation could not pass until after the current recriminalization date.

Comer told the panel at Monday’s meeting that his amendment would “protect American farmers” and “help the hemp industry and the thousands of jobs that use and rely on these products.”

“It is clear that Congress needs more time to pass legislation that protects jobs, eliminates bad actors, standardizes labeling and requires third-party testing,” he said. “My amendment would give Congress another year, until November 2027, to develop this solution.”

It is not clear why he decided to remove it from the annex to the proposal Farm BillAlso known as the Farm, Food, and National Security Act of 2026, or HR 7567.




Griffith, a member of the Rules Committee who sponsored Comer’s amendment, noted that there are “a lot of hemp products from overseas that don’t have third-party testing” on the market, “frankly all kinds of junk.”

He said the real solution is for the Food and Drug Administration (FDA) to regulate the products, citing a separate bill he has introduced on the issue, but argued that “we have to have time to adjust,” which he said would provide the delay amendment.

Meanwhile, Rep. Andy Barr (R-KY) also introduced an amendment to the bill that, according to the sponsor’s summary, “changes the definition of hemp to protect the legal hemp market, creating a regulatory framework that protects children, bans synthetics, and ensures that products on the market are of American origin.”

The congressman later withdrew the proposal for undisclosed reasons.

However, he recently received a letter White House officials commented on pending legislation to create a regulatory framework for hemp.

Last week, Vince Haley, director of the White House Domestic Policy Council, and James Braid, assistant to the president for legislative affairs, sent hemp policy suggestions to Barr, who is helping lead efforts to establish regulations for the plant as an alternative to prohibition.

“We appreciate your work to advance policy,” the executive order Trump signed in December, which included provisions to protect Americans’ access to CBD products, the staff wrote in a letter to Congress.

“We are submitting draft legislation and comments to your account to address the final statutory definition of hemp-derived cannabinoid products to ensure that Americans have access to adequate full-spectrum CBD products while maintaining Congress’ intent to limit the sale of products that pose serious health risks,” White House officials said, according to a social media screencast. “We are open to discussion and further technical assistance.”

The annex to the administration’s proposed legislative text has not been released publicly, and the White House and Barr’s office did not immediately respond to Marihuana Moment’s request for more details.

It’s not clear from the text of the letter whether the White House was proactively sending legislative proposals to the lawmaker or whether they were responding to something sent by his office, though two cannabis industry sources suggested to Marihuana Moment that Barr was sending the language to the administration, and then providing technical feedback.

Trump this week It inspired lawmakers in Congress to take action to change the currently planned hemp banand suggested that this threatens to federally recriminalize full-spectrum CBD products.

“I’m calling on Congress to update the Act so Americans can continue to have access to the full-spectrum CBD products they trust and support, while maintaining Congress’ intent to restrict the sale of products that pose health risks,” the president said in a Truth Social message Thursday, the same day his administration announced it is moving forward to re-regulate marijuana.

“We need to do this RIGHT and FAST, especially for those who have found CBD to help them,” he said. “Also, I’m told it will help our BIG FARMERS that we love and will always be around.”

Rep. Jim Baird (R-IN) had it introduced the hemp ban delay amendment before the House Agriculture Committee when it took up the Farm Bill last month, but the president of that panel determined that the proposal was not in line with the legislation.

The Farm Bill passed by the previous committee includes provisions to help the hemp industry and farmers who grow cannabis for industrial purposes, such as fiber and grain. For example, the legislation would amend statutes related to states and tribes developing regulatory plans for industrial hemp production, including policies on testing, sampling, background checks and record keeping.

Other bipartisan hemp reform bills are pending in Congress.

This month, for example, it was introduced by Senators Rand Paul (R-KY), Amy Klobuchar (D-MN) and Joni Ernst (R-IA). The Hemp Safety Enforcement Act, which would give states the option of federal recriminalization of THC hemp products. it will be established this year.

Ernst withdrew his name, however, as a sponsor of the legislation. His office did not respond to Marihuana Moment’s request for clarification on the move.


It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

The US Department of Agriculture published this month shows that US farmers grow $3 billion in hemp crops by 2025— 64% increase compared to the previous year.

Meanwhile, this month the Trump administration launched a new initiative Cover up to $500 of hemp-derived products annually for eligible Medicare patients. The program being implemented by the Centers for Medicare and Medicaid Services (CMS) focuses largely on CBD, but also allows a certain amount of THC in products.

Anti-marijuana organizations filed a lawsuit against the Medicare hemp coverage policyand Health and Human Services attorneys. Robert F. Kennedy Jr. and CMS Director Mehmet Oz recently He submitted a letter requesting the filing of the case.

Meanwhile, the White House Management and Budget Office has held a series of meetings a Food and Drug Administration (FDA) CBD product enforcement policy.

The FDA also issued guidance making it clear that it does not intend to interfere Establish a Medicare coverage plan for hemp-derived products.

CMS finalized a rule that will be adopted separately Coverage of certain hemp products, primarily as specialized health-related benefits, through Medicare Advantage the plans

As hemp products become more popular among consumers, some big brands are trying to get in on the action.

The main retailer Target, for example, is expanding its involvement in the hemp-derived THC beverage market. Last year, the company began a pilot program in 10 stores in Minnesota that sell cannabis drinks. That apparently went well, and now the company has secured licenses from Minnesota regulators to sell lower-potency edible hemp products — including THC drinks — in 72 stores in the state.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

NC lawmakers revisit marijuana policy following reclassification

Published

on

By











North Carolina lawmakers say they’re fueling debate over the state’s marijuana laws — a move by the Trump administration to reclassify it as a less dangerous drug.

Across the country, a set of laws and enforcements regulate marijuana. The drug is illegal under federal law, but dozens of US states have legalized it. And almost all states have legalized medical marijuana prescriptions for certain ailments. North Carolina is among the remaining states to resist any form of legalization. Republican politicians in North Carolina have resisted passing any bills to legalize or decriminalize marijuana, despite public opinion polls showing broad public support for such changes.

Senate President Phil Berger said he expects his chamber to revisit efforts to legalize medical marijuana this week. “We will have a conversation within our caucus if they are interested in whether we do something,” Berger told reporters Tuesday.

The recent actions of Republican President Donald Trump may add a new dimension to these conversations. Trump’s acting attorney general on Thursday signed the drug classification as a less dangerous and less strictly regulated drug than marijuana. Federal law does not legalize marijuana for medical or recreational use.

Read more at WRAL News










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media